Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer.

Lawlor DA, J√ľni P, Ebrahim S, Egger M.

J Clin Epidemiol. 2003 Feb;56(2):155-63. Review.

PMID:
12654410
2.

Use of antidepressant medications and the possible association with breast cancer risk. A review.

Bahl S, Cotterchio M, Kreiger N.

Psychother Psychosom. 2003 Jul-Aug;72(4):185-94. Review.

PMID:
12792123
3.

Epidemiologic issues related to the association between physical activity and breast cancer.

Friedenreich CM, Thune I, Brinton LA, Albanes D.

Cancer. 1998 Aug 1;83(3 Suppl):600-10. Review.

PMID:
9690523
4.

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.

PMID:
16150813
5.

Review of the epidemiological literature on antidepressant use and breast cancer risk.

Coogan PF.

Expert Rev Neurother. 2006 Sep;6(9):1363-74. Review.

PMID:
17009923
6.

Alcohol drinking and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.

Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan.

Jpn J Clin Oncol. 2007 Aug;37(8):568-74. Epub 2007 Aug 18. Review.

PMID:
17704531
7.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
8.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
9.

Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population.

Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan.

Jpn J Clin Oncol. 2006 Jun;36(6):387-94. Epub 2006 Jun 9. Review.

PMID:
16766567
10.

Physical activity and breast cancer: a systematic review.

Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, van Leeuwen FE; TFPAC.

Epidemiology. 2007 Jan;18(1):137-57. Review.

PMID:
17130685
11.

Hormone replacement therapy after cancers.

Creasman WT.

Curr Opin Oncol. 2005 Sep;17(5):493-9. Review.

PMID:
16093802
12.

In vitro fertilization and breast cancer risk: a review.

Salhab M, Al Sarakbi W, Mokbel K.

Int J Fertil Womens Med. 2005 Nov-Dec;50(6):259-66. Review.

PMID:
16526416
13.
14.

Environmental exposure to polychlorinated biphenyls and breast cancer risk.

Moysich KB, Menezes RJ, Baker JA, Falkner KL.

Rev Environ Health. 2002 Oct-Dec;17(4):263-77. Review.

PMID:
12611469
15.

Use of common medications and breast cancer risk.

Moysich KB, Beehler GP, Zirpoli G, Choi JY, Baker JA.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1564-95. doi: 10.1158/1055-9965.EPI-07-2828. Review.

16.

Carcinogenicity of antihypertensive therapy.

Grossman E, Messerli FH, Goldbourt U.

Curr Hypertens Rep. 2002 Jun;4(3):195-201. Review.

PMID:
12003701
17.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
19.

The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis.

Seely D, Mills EJ, Wu P, Verma S, Guyatt GH.

Integr Cancer Ther. 2005 Jun;4(2):144-55. Review.

PMID:
15911927
20.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322

Supplemental Content

Support Center